John R. Mackey
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 59
- Cancer survivorship and care 55
- HER2/EGFR in Cancer Research 44
- Lymphatic System and Diseases 28
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 35
- Physiology top 0.1%
- Adenosine and Purinergic Signaling 25
-
- Childhood Cancer Survivors' Quality of Life 36
- Pulmonary and Respiratory Medicine top 0.2%
-
- Chemotherapy-induced cardiotoxicity and mitigation 31
- Co-authors
- Kerry S. CourneyaLee W. JonesCarol E. CassCharles DumontetMark J. HaykowskyAdrian FaireyKaren A. GelmonEvangelos D. Michelakis
- Cited by
- OncologyCancer ResearchPhysiology
- Journals
- Journal of Clinical Oncology (42 papers)Clinical Cancer Research (13 papers)Cancer (12 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
John R. Mackey
327 papers receiving 23.9k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Oncology 14.8k
- Cancer Research 4.0k
- Physiology 1.1k
- Pediatrics, Perinatology and Child Health 3.1k
- Pulmonary and Respiratory Medicine 4.6k
Countries citing papers authored by John R. Mackey
This map shows the geographic impact of John R. Mackey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Mackey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Mackey more than expected).
Fields of papers citing papers by John R. Mackey
This network shows the impact of papers produced by John R. Mackey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Mackey. The network helps show where John R. Mackey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John R. Mackey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 28 | |
| 8 | 2020 | 50 | |
| 9 | 2019 | 47 | |
| 10 | 2015 | 57 | |
| 11 | 2013 | 19 | |
| 12 | 2012 | 141 | |
| 13 | 2010 | 238 | |
| 14 | 2010 | 33 | |
| 15 | 2010 | 23 | |
| 16 | 2009 | 71 | |
| 17 | 2008 | 306 | |
| 18 | 2008 | 331 | |
| 19 | 2008 | 164 | |
| 20 | Effects of Exercise Training on Fasting Insulin, Insulin Resistance, Insulin-like Growth Factors, and Insulin-like Growth Factor Binding Proteins in Postmenopausal Breast Cancer Survivors | 2003 | 4 |
About John R. Mackey
John R. Mackey is a scholar working on Oncology, Physiology and Cancer Research, having authored 335 papers that have together received 24.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (59 papers), Cancer survivorship and care (55 papers), HER2/EGFR in Cancer Research (44 papers), Childhood Cancer Survivors' Quality of Life (36 papers), Breast Cancer Treatment Studies (35 papers), Chemotherapy-induced cardiotoxicity and mitigation (31 papers), Lymphatic System and Diseases (28 papers) and Adenosine and Purinergic Signaling (25 papers). The work is most often cited by research in Oncology (14.8k citations), Cancer Research (4.0k citations) and Physiology (1.1k citations). John R. Mackey has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Kerry S. Courneya, Lee W. Jones, Carol E. Cass, Charles Dumontet, Mark J. Haykowsky, Adrian Fairey, Karen A. Gelmon, Evangelos D. Michelakis, Christine M. Friedenreich and Donald C. McKenzie. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Cancer Research and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.